Insitrex-TZ 281.25 Injection
Marketer
Insinius Pharmaceuticals
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Insitrex-TZ 281.25 Injection
Insitrex-TZ 281.25 Injection, a dual-action medication, combats various bacterial infections. Its mechanism inhibits microbial proliferation, thus containing infection spread. Administration must be under a healthcare provider's direct guidance; consistent adherence to the prescribed regimen is crucial, even with symptom improvement. Premature cessation may compromise treatment efficacy. Typical mild reactions include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms require immediate medical attention. Allergic responses (skin rashes, itching, edema, respiratory distress) necessitate prompt medical intervention. Prior to commencing treatment, disclose all current medications and pre-existing conditions to your physician. This is particularly important for pregnant or lactating individuals. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operation of vehicles if experiencing somnolence or vertigo. Adequate rest, balanced nutrition, and sufficient hydration are essential for optimal recovery. Your doctor may order blood tests and other assessments to monitor therapeutic response.
Uses of Insitrex-TZ 281.25 Injection
Infections caused by bacteria
Major Benefits of Insitrex-TZ 281.25 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Insitrex-TZ 281.25 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Insitrex-TZ 281.25 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Insitrex-TZ 281.25 Injection works:
Insitrex-TZ 281.25 Injection unites Ceftriaxone, a bacterial growth inhibitor, with Tazobactum, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their survival. Tazobactum counteracts bacterial resistance mechanisms, thereby augmenting Ceftriaxone's antibiotic efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from combining Insitrex-TZ 281.25 Injection with alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Insitrex-TZ 281.25 is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
The administration of Insitrex-TZ 281.25 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Insitrex-TZ 281.25 Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Insitrex-TZ 281.25 Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Individuals with severe hepatic impairment should use Insitrex-TZ 281.25 Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Dosage alterations for Insitrex-TZ 281.25 Injection are unnecessary for those with mild or moderate liver dysfunction.
What if you forget to take Insitrex-TZ 281.25 Injection :
Omit a scheduled Insitrex-TZ 281.25 Injection? Seek medical advice immediately.
Facts to Know About Insitrex-TZ 281.25 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |
3,018 People bought this recently